Anesthesia & Analgesia, ISSN 0003-2999, 11/2019, Volume 129, Issue 5, pp. 1232 - 1239
BACKGROUND:Albumin may persist intravascularly for a shorter time in patients after major surgery than in healthy volunteers due to a surgery-induced breakdown...
SURGERY | FLUID EXCHANGE | ENDOTHELIAL GLYCOCALYX | EXPANSION | ANESTHESIOLOGY | 5-PERCENT ALBUMIN | INFUSION | BLOOD-VOLUME | MICROVASCULAR PERMEABILITY | Measurement | Serum albumin | Health aspects | Postoperative care | Patient outcomes | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Anestesi och intensivvård | Anesthesiology and Intensive Care
SURGERY | FLUID EXCHANGE | ENDOTHELIAL GLYCOCALYX | EXPANSION | ANESTHESIOLOGY | 5-PERCENT ALBUMIN | INFUSION | BLOOD-VOLUME | MICROVASCULAR PERMEABILITY | Measurement | Serum albumin | Health aspects | Postoperative care | Patient outcomes | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Anestesi och intensivvård | Anesthesiology and Intensive Care
Journal Article
Journal of Clinical Pharmacy and Therapeutics, ISSN 0269-4727, 10/2018, Volume 43, Issue 5, pp. 746 - 751
Summary What is known and Objective The purpose of this critical narrative review is to analyse studies evaluating the disposition of albumin in critically ill...
pharmacokinetics | transcapillary escape rate | disposition | half‐life | distribution | albumin | half-life | HUMAN SERUM-ALBUMIN | VOLUME | 5-PERCENT ALBUMIN | OSMOTIC-PRESSURE | NORMAL SALINE | VASCULAR-PERMEABILITY | SEPTIC PATIENTS | DISAPPEARANCE | HUMAN PLASMA FRACTIONATION | PHARMACOLOGY & PHARMACY | Critical Illness | Prospective Studies | Albumins - metabolism | Humans | Shock, Septic - metabolism | Albumin | Medicine, Experimental | Medical research | Septic shock | Disease control | Patients | Surgery | Acuity
pharmacokinetics | transcapillary escape rate | disposition | half‐life | distribution | albumin | half-life | HUMAN SERUM-ALBUMIN | VOLUME | 5-PERCENT ALBUMIN | OSMOTIC-PRESSURE | NORMAL SALINE | VASCULAR-PERMEABILITY | SEPTIC PATIENTS | DISAPPEARANCE | HUMAN PLASMA FRACTIONATION | PHARMACOLOGY & PHARMACY | Critical Illness | Prospective Studies | Albumins - metabolism | Humans | Shock, Septic - metabolism | Albumin | Medicine, Experimental | Medical research | Septic shock | Disease control | Patients | Surgery | Acuity
Journal Article
Journal of Critical Care, ISSN 0883-9441, 2016, Volume 35, pp. 161 - 167
Abstract Fluid administration is a key intervention in hemodynamic resuscitation. Timely expansion (or restoration) of plasma volume may prevent tissue hypoxia...
Critical Care | Albumin | Microcirculation | Nephrotoxicity | Colloids | Resuscitation | Crystalloids | ACUTE KIDNEY INJURY | SERUM-ALBUMIN | HYDROXYETHYL STARCH | RESUSCITATION FLUIDS | 5-PERCENT ALBUMIN | BLOOD-FLOW | MICROVASCULAR PERMEABILITY | 0.9-PERCENT NACL | ENDOTHELIAL GLYCOCALYX | MICROCIRCULATORY ALTERATIONS | CRITICAL CARE MEDICINE | Critical Care - methods | Albumins - therapeutic use | Hypoalbuminemia - therapy | Isotonic Solutions - therapeutic use | Resuscitation - methods | Fluid Therapy - methods | Humans | Sepsis - therapy | Critical Illness - therapy | Colloids - therapeutic use | Shock, Hemorrhagic - therapy | Shock, Septic - therapy | Septic shock | Permeability | Liver cirrhosis | Index Medicus
Critical Care | Albumin | Microcirculation | Nephrotoxicity | Colloids | Resuscitation | Crystalloids | ACUTE KIDNEY INJURY | SERUM-ALBUMIN | HYDROXYETHYL STARCH | RESUSCITATION FLUIDS | 5-PERCENT ALBUMIN | BLOOD-FLOW | MICROVASCULAR PERMEABILITY | 0.9-PERCENT NACL | ENDOTHELIAL GLYCOCALYX | MICROCIRCULATORY ALTERATIONS | CRITICAL CARE MEDICINE | Critical Care - methods | Albumins - therapeutic use | Hypoalbuminemia - therapy | Isotonic Solutions - therapeutic use | Resuscitation - methods | Fluid Therapy - methods | Humans | Sepsis - therapy | Critical Illness - therapy | Colloids - therapeutic use | Shock, Hemorrhagic - therapy | Shock, Septic - therapy | Septic shock | Permeability | Liver cirrhosis | Index Medicus
Journal Article
4.
Full Text
Human albumin solution for resuscitation and volume expansion in critically ill patients
The Cochrane database of systematic reviews, ISSN 1469-493X, 2011, Issue 11, p. CD001208
Background Human albumin solutions are used for a range of medical and surgical problems. Licensed indications are the emergency treatment of shock and other...
Fluid Therapy | HYPOALBUMINEMIC PATIENTS | Humans | Plasma Substitutes [therapeutic use] | 5-PERCENT ALBUMIN | NORMAL SALINE | Critical Illness [mortality; therapy] | RANDOMIZED CONTROLLED-TRIAL | Randomized Controlled Trials as Topic | FLUID RESUSCITATION | Serum Globulins | Blood Proteins [therapeutic use] | TOTAL PARENTERAL-NUTRITION | MEDICINE, GENERAL & INTERNAL | INTENSIVE-CARE-UNIT | COLLOID OSMOTIC-PRESSURE | Serum Albumin [therapeutic use] | CEREBRAL-BLOOD-FLOW | MAJOR SURGERY | Burns - mortality | Hypoproteinemia - mortality | Burns - blood | Serum Albumin - administration & dosage | Hypovolemia - mortality | Cause of Death | Serum Albumin - adverse effects | Hypoproteinemia - blood | Critical Illness - mortality | Hypovolemia - blood | Plasma Substitutes - administration & dosage | Blood Volume | Critical Illness - therapy | Burns - therapy | Hypoproteinemia - therapy | Hypovolemia - therapy | Plasma Substitutes - adverse effects
Fluid Therapy | HYPOALBUMINEMIC PATIENTS | Humans | Plasma Substitutes [therapeutic use] | 5-PERCENT ALBUMIN | NORMAL SALINE | Critical Illness [mortality; therapy] | RANDOMIZED CONTROLLED-TRIAL | Randomized Controlled Trials as Topic | FLUID RESUSCITATION | Serum Globulins | Blood Proteins [therapeutic use] | TOTAL PARENTERAL-NUTRITION | MEDICINE, GENERAL & INTERNAL | INTENSIVE-CARE-UNIT | COLLOID OSMOTIC-PRESSURE | Serum Albumin [therapeutic use] | CEREBRAL-BLOOD-FLOW | MAJOR SURGERY | Burns - mortality | Hypoproteinemia - mortality | Burns - blood | Serum Albumin - administration & dosage | Hypovolemia - mortality | Cause of Death | Serum Albumin - adverse effects | Hypoproteinemia - blood | Critical Illness - mortality | Hypovolemia - blood | Plasma Substitutes - administration & dosage | Blood Volume | Critical Illness - therapy | Burns - therapy | Hypoproteinemia - therapy | Hypovolemia - therapy | Plasma Substitutes - adverse effects
Journal Article
Annals of Thoracic Surgery, ISSN 0003-4975, 2016, Volume 104, Issue 1, pp. 42 - 48
Background Volume expansion is often necessary after cardiac surgery, and albumin is often administered. Albumin’s high cost motivated an attempt to reduce its...
Surgery | Cardiothoracic Surgery | CONTROLLED-TRIALS | MORTALITY | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | RESPIRATORY SYSTEM | HYDROXYETHYL STARCH | GUIDELINES | NORMAL SALINE | COLLOIDS | COHORT | 5-PERCENT | Critical Care - methods | Maryland - epidemiology | Survival Rate - trends | Follow-Up Studies | Hypoalbuminemia - drug therapy | Outcome Assessment (Health Care) | Humans | Intensive Care Units - economics | Albumins - administration & dosage | Treatment Outcome | Cardiac Surgical Procedures - adverse effects | Critical Care - economics | Hospital Mortality - trends | Drug Costs - trends | Hypoalbuminemia - mortality | Albumins - economics | Cost-Benefit Analysis | Retrospective Studies | Infusions, Intravenous | Albumin | Medical colleges | Analysis | Pharmacy | Mortality | Cardiac patients | Drugstores | Medical care | Health aspects | Quality management
Surgery | Cardiothoracic Surgery | CONTROLLED-TRIALS | MORTALITY | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | RESPIRATORY SYSTEM | HYDROXYETHYL STARCH | GUIDELINES | NORMAL SALINE | COLLOIDS | COHORT | 5-PERCENT | Critical Care - methods | Maryland - epidemiology | Survival Rate - trends | Follow-Up Studies | Hypoalbuminemia - drug therapy | Outcome Assessment (Health Care) | Humans | Intensive Care Units - economics | Albumins - administration & dosage | Treatment Outcome | Cardiac Surgical Procedures - adverse effects | Critical Care - economics | Hospital Mortality - trends | Drug Costs - trends | Hypoalbuminemia - mortality | Albumins - economics | Cost-Benefit Analysis | Retrospective Studies | Infusions, Intravenous | Albumin | Medical colleges | Analysis | Pharmacy | Mortality | Cardiac patients | Drugstores | Medical care | Health aspects | Quality management
Journal Article
SHOCK, ISSN 1073-2322, 09/2018, Volume 50, Issue 3, pp. 366 - 372
BACKGROUND:Dextran-70 is a more potent plasma volume expander than albumin but use has been hampered because of its antithrombotic properties. However, also...
Whole blood | Plasma volume | Thrombelastography | Fibrinogen | Von Willebrand factor | SURGERY | ACTIVATION | thrombelastography | HYDROXYETHYL STARCH | plasma volume | whole blood | COAGULOPATHY | INHIBITION | von Willebrand factor | PERIPHERAL VASCULAR DISEASE | SALINE | HEMATOLOGY | 5-PERCENT | SEVERE SEPSIS | BLOOD | RESUSCITATION | CRITICAL CARE MEDICINE | Dextran | Care and treatment | Usage | Guinea pigs | Albumin | Hemorrhage | Health aspects | Basic Science Aspects | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Anestesi och intensivvård | Anesthesiology and Intensive Care
Whole blood | Plasma volume | Thrombelastography | Fibrinogen | Von Willebrand factor | SURGERY | ACTIVATION | thrombelastography | HYDROXYETHYL STARCH | plasma volume | whole blood | COAGULOPATHY | INHIBITION | von Willebrand factor | PERIPHERAL VASCULAR DISEASE | SALINE | HEMATOLOGY | 5-PERCENT | SEVERE SEPSIS | BLOOD | RESUSCITATION | CRITICAL CARE MEDICINE | Dextran | Care and treatment | Usage | Guinea pigs | Albumin | Hemorrhage | Health aspects | Basic Science Aspects | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Anestesi och intensivvård | Anesthesiology and Intensive Care
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 2016, Volume 14, Issue 1, p. 60
Background: Volume resuscitation with hydroxyethyl starch (HES) is controversially discussed and we recently showed that HES perfusion impairs endothelial and...
Erk1/2 | I-FABP | Intestine | Albumin | Akt | Fluid substitution | Hydroxyethyl starch | Intestinal barrier integrity | Resuscitation | MEDICINE, RESEARCH & EXPERIMENTAL | PERMEABILITY | INTENSIVE-CARE | SPHINGOSINE 1-PHOSPHATE | FLUID RESUSCITATION | EPITHELIAL-CELLS | ENDOTHELIAL GLYCOCALYX | 5-PERCENT HUMAN ALBUMIN | PROTECTIVE ROLES | INFLAMMATORY RESPONSE | Intestines - drug effects | Intestines - pathology | Epithelial Cells - drug effects | Mice, Inbred C57BL | Intestines - metabolism | Colloids - pharmacology | Albumins - pharmacology | Animals | Signal Transduction - drug effects | Solutions | Perfusion | Phosphorylation - drug effects | Endothelial Cells - drug effects | Hydroxyethyl Starch Derivatives - adverse effects | Shock | Care and treatment | Analysis | Permeability | Research | Phosphotransferases | Health aspects
Erk1/2 | I-FABP | Intestine | Albumin | Akt | Fluid substitution | Hydroxyethyl starch | Intestinal barrier integrity | Resuscitation | MEDICINE, RESEARCH & EXPERIMENTAL | PERMEABILITY | INTENSIVE-CARE | SPHINGOSINE 1-PHOSPHATE | FLUID RESUSCITATION | EPITHELIAL-CELLS | ENDOTHELIAL GLYCOCALYX | 5-PERCENT HUMAN ALBUMIN | PROTECTIVE ROLES | INFLAMMATORY RESPONSE | Intestines - drug effects | Intestines - pathology | Epithelial Cells - drug effects | Mice, Inbred C57BL | Intestines - metabolism | Colloids - pharmacology | Albumins - pharmacology | Animals | Signal Transduction - drug effects | Solutions | Perfusion | Phosphorylation - drug effects | Endothelial Cells - drug effects | Hydroxyethyl Starch Derivatives - adverse effects | Shock | Care and treatment | Analysis | Permeability | Research | Phosphotransferases | Health aspects
Journal Article
8.
Full Text
Human albumin solution for resuscitation and volume expansion in critically ill patients
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2011, Issue 10, p. CD001208
Background Human albumin solutions are used for a range of medical and surgical problems. Licensed indications are the emergency treatment of shock and other...
Fluid Therapy | HYPOALBUMINEMIC PATIENTS | Humans | Plasma Substitutes [therapeutic use] | 5-PERCENT ALBUMIN | NORMAL SALINE | Critical Illness [mortality; therapy] | RANDOMIZED CONTROLLED-TRIAL | Randomized Controlled Trials as Topic | FLUID RESUSCITATION | Serum Globulins | Blood Proteins [therapeutic use] | MEDICINE, GENERAL & INTERNAL | ONCOTIC PRESSURE | PARENTERAL-NUTRITION | COLLOID OSMOTIC-PRESSURE | Serum Albumin [therapeutic use] | CEREBRAL-BLOOD-FLOW | MAJOR SURGERY | Burns - mortality | Plasma Substitutes - therapeutic use | Hypovolemia - mortality | Blood Proteins - therapeutic use | Serum Albumin - therapeutic use | Hypoalbuminemia - mortality | Hypoalbuminemia - therapy | Critical Illness - mortality | Critical Illness - therapy | Burns - therapy | Hypovolemia - therapy
Fluid Therapy | HYPOALBUMINEMIC PATIENTS | Humans | Plasma Substitutes [therapeutic use] | 5-PERCENT ALBUMIN | NORMAL SALINE | Critical Illness [mortality; therapy] | RANDOMIZED CONTROLLED-TRIAL | Randomized Controlled Trials as Topic | FLUID RESUSCITATION | Serum Globulins | Blood Proteins [therapeutic use] | MEDICINE, GENERAL & INTERNAL | ONCOTIC PRESSURE | PARENTERAL-NUTRITION | COLLOID OSMOTIC-PRESSURE | Serum Albumin [therapeutic use] | CEREBRAL-BLOOD-FLOW | MAJOR SURGERY | Burns - mortality | Plasma Substitutes - therapeutic use | Hypovolemia - mortality | Blood Proteins - therapeutic use | Serum Albumin - therapeutic use | Hypoalbuminemia - mortality | Hypoalbuminemia - therapy | Critical Illness - mortality | Critical Illness - therapy | Burns - therapy | Hypovolemia - therapy
Journal Article
Current Opinion in Critical Care, ISSN 1070-5295, 2016, Volume 22, Issue 5, pp. 428 - 436
Purpose of reviewThe review focuses on fluid resuscitation of critically ill patients with either colloid or crystalloid solutions.Recent findingsIn healthy...
crystalloids | colloids | gelatin | albumin | hydroxyethyl starches | ACUTE KIDNEY INJURY | STARLING PRINCIPLE | HYDROXYETHYL STARCH | 5-PERCENT ALBUMIN | RANDOMIZED CONTROLLED-TRIAL | FLUID RESUSCITATION | INTENSIVE-CARE-UNIT | ENDOTHELIAL GLYCOCALYX | COLLOID SOLUTIONS | SEVERE SEPSIS | CRITICAL CARE MEDICINE | Albumins - therapeutic use | Isotonic Solutions - therapeutic use | Resuscitation - methods | Fluid Therapy - methods | Gelatin - therapeutic use | Humans | Isotonic Solutions - administration & dosage | Critical Illness - therapy | Treatment Outcome | Rehydration Solutions - therapeutic use
crystalloids | colloids | gelatin | albumin | hydroxyethyl starches | ACUTE KIDNEY INJURY | STARLING PRINCIPLE | HYDROXYETHYL STARCH | 5-PERCENT ALBUMIN | RANDOMIZED CONTROLLED-TRIAL | FLUID RESUSCITATION | INTENSIVE-CARE-UNIT | ENDOTHELIAL GLYCOCALYX | COLLOID SOLUTIONS | SEVERE SEPSIS | CRITICAL CARE MEDICINE | Albumins - therapeutic use | Isotonic Solutions - therapeutic use | Resuscitation - methods | Fluid Therapy - methods | Gelatin - therapeutic use | Humans | Isotonic Solutions - administration & dosage | Critical Illness - therapy | Treatment Outcome | Rehydration Solutions - therapeutic use
Journal Article
CARDIOVASCULAR RESEARCH, ISSN 0008-6363, 02/2007, Volume 73, Issue 3, pp. 575 - 586
Objective: To test the role of an oncotic pressure gradient across the endothelial glycocalyx with respect to extravasation of fluid and colloids and...
endothelial function | CARDIAC & CARDIOVASCULAR SYSTEMS | ATRIAL-NATRIURETIC-PEPTIDE | PERMEABILITY | capillaries | BARRIER | 5-PERCENT ALBUMIN | FILTRATION | microcirculation | FROG MESENTERIC CAPILLARIES | FLOW | coronary circulation | CORONARY VASCULAR BED | FLUID | capillary permeability | SURFACE
endothelial function | CARDIAC & CARDIOVASCULAR SYSTEMS | ATRIAL-NATRIURETIC-PEPTIDE | PERMEABILITY | capillaries | BARRIER | 5-PERCENT ALBUMIN | FILTRATION | microcirculation | FROG MESENTERIC CAPILLARIES | FLOW | coronary circulation | CORONARY VASCULAR BED | FLUID | capillary permeability | SURFACE
Journal Article
11.
Full Text
Infusion rate and plasma volume expansion of dextran and albumin in the septic guinea pig
Acta Anaesthesiologica Scandinavica, ISSN 0001-5172, 01/2014, Volume 58, Issue 1, pp. 44 - 51
Background Intravenous fluid treatment of hypovolaemia in states of increased capillary permeability, e.g. sepsis, is often accompanied by adverse oedema...
INTERSTITIAL FLUID PRESSURE | REPLACEMENT | GELATIN | CAPILLARY-PERMEABILITY | 6-PERCENT HES 130/0.4 | MACROMOLECULES | TRANSCAPILLARY ESCAPE RATE | CONSEQUENCES | ANESTHESIOLOGY | 5-PERCENT ALBUMIN | EXCHANGE | Guinea Pigs | Plasma Substitutes - pharmacology | Albumins - administration & dosage | Male | Sepsis - physiopathology | Plasma Volume | Urodynamics - physiology | Albumins - pharmacology | Animals | Dextrans - pharmacology | Plasma Substitutes - administration & dosage | Sepsis - therapy | Infusions, Intravenous | Dextrans - administration & dosage | Dextran | Albumin | Permeability | Analysis | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Anestesi och intensivvård | Anesthesiology and Intensive Care
INTERSTITIAL FLUID PRESSURE | REPLACEMENT | GELATIN | CAPILLARY-PERMEABILITY | 6-PERCENT HES 130/0.4 | MACROMOLECULES | TRANSCAPILLARY ESCAPE RATE | CONSEQUENCES | ANESTHESIOLOGY | 5-PERCENT ALBUMIN | EXCHANGE | Guinea Pigs | Plasma Substitutes - pharmacology | Albumins - administration & dosage | Male | Sepsis - physiopathology | Plasma Volume | Urodynamics - physiology | Albumins - pharmacology | Animals | Dextrans - pharmacology | Plasma Substitutes - administration & dosage | Sepsis - therapy | Infusions, Intravenous | Dextrans - administration & dosage | Dextran | Albumin | Permeability | Analysis | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Anestesi och intensivvård | Anesthesiology and Intensive Care
Journal Article
The Annals of Thoracic Surgery, ISSN 0003-4975, 2001, Volume 72, Issue 2, pp. 527 - 533
Background. This meta-analysis tested the hypothesis that cumulative blood loss during the first 24 hours after cardiopulmonary bypass is lower in patients...
VOLUME EXPANSION | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | BLOOD-LOSS | RANDOMIZED CLINICAL-TRIAL | PLATELET-FUNCTION | PRIMING SOLUTION | 5-PERCENT ALBUMIN | 10-PERCENT PENTASTARCH | HETASTARCH | RESPIRATORY SYSTEM | CARDIAC-SURGERY | OPEN-HEART-SURGERY
VOLUME EXPANSION | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | BLOOD-LOSS | RANDOMIZED CLINICAL-TRIAL | PLATELET-FUNCTION | PRIMING SOLUTION | 5-PERCENT ALBUMIN | 10-PERCENT PENTASTARCH | HETASTARCH | RESPIRATORY SYSTEM | CARDIAC-SURGERY | OPEN-HEART-SURGERY
Journal Article
Critical Care, ISSN 1364-8535, 03/2008, Volume 12, Issue 2, pp. R34 - R34
Background Small-volume resuscitation can rapidly correct hypovolemia. Hyperoncotic albumin solutions, long in clinical use, are suitable for small-volume...
COLLOID ONCOTIC THERAPY | PROTEIN EXTRAVASATION | HYDROXYETHYL STARCH SOLUTION | SERUM-ALBUMIN | FOCAL CEREBRAL-ISCHEMIA | RENAL-FUNCTION | CRITICALLY-ILL | 5-PERCENT ALBUMIN | NORMAL SALINE | BLOOD-VOLUME | CRITICAL CARE MEDICINE | Albumins - therapeutic use | Plasma Substitutes - therapeutic use | Resuscitation - methods | Solutions | Humans | Hypovolemia - therapy | Edema - prevention & control | Randomized Controlled Trials as Topic | Albumin | Care and treatment | Research | Blood diseases | Health aspects | Resuscitation
COLLOID ONCOTIC THERAPY | PROTEIN EXTRAVASATION | HYDROXYETHYL STARCH SOLUTION | SERUM-ALBUMIN | FOCAL CEREBRAL-ISCHEMIA | RENAL-FUNCTION | CRITICALLY-ILL | 5-PERCENT ALBUMIN | NORMAL SALINE | BLOOD-VOLUME | CRITICAL CARE MEDICINE | Albumins - therapeutic use | Plasma Substitutes - therapeutic use | Resuscitation - methods | Solutions | Humans | Hypovolemia - therapy | Edema - prevention & control | Randomized Controlled Trials as Topic | Albumin | Care and treatment | Research | Blood diseases | Health aspects | Resuscitation
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 07/2012, Volume 2017, Issue 12, p. CD001319
Background Colloids are widely used in the replacement of fluid volume. However, doubts remain as to which colloid is best. Different colloids vary in their...
Fluid Therapy | POSTOPERATIVE VOLUME EXPANSION | CARDIAC SURGICAL-PATIENTS | Hetastarch [therapeutic use] | Humans | HUMAN-ALBUMIN 5-PERCENT | Albumins [therapeutic use] | RANDOMIZED CLINICAL-TRIAL | CRITICALLY-ILL | CARDIOPULMONARY BYPASS | Critical Illness [therapy] | PLASMA-VOLUME | Randomized Controlled Trials as Topic | Blood Proteins [therapeutic use] | MEDICINE, GENERAL & INTERNAL | Colloids [adverse effects; therapeutic use] | RETRACTED ARTICLE. SEE | Dextrans [adverse effects; therapeutic use] | HYDROXYETHYL STARCH SOLUTION | MAJOR ORTHOPEDIC-SURGERY | Plasma Substitutes [adverse effects; therapeutic use] | Rehydration Solutions [adverse effects; therapeutic use] | Plasma Substitutes - therapeutic use | Resuscitation - methods | Fluid Therapy - mortality | Colloids - therapeutic use | Blood Proteins - therapeutic use | Serum Albumin, Human | Serum Albumin - therapeutic use | Fluid Therapy - methods | Serum Globulins - therapeutic use | Hydroxyethyl Starch Derivatives - therapeutic use | Dextrans - therapeutic use | Rehydration Solutions - therapeutic use | Resuscitation - mortality
Fluid Therapy | POSTOPERATIVE VOLUME EXPANSION | CARDIAC SURGICAL-PATIENTS | Hetastarch [therapeutic use] | Humans | HUMAN-ALBUMIN 5-PERCENT | Albumins [therapeutic use] | RANDOMIZED CLINICAL-TRIAL | CRITICALLY-ILL | CARDIOPULMONARY BYPASS | Critical Illness [therapy] | PLASMA-VOLUME | Randomized Controlled Trials as Topic | Blood Proteins [therapeutic use] | MEDICINE, GENERAL & INTERNAL | Colloids [adverse effects; therapeutic use] | RETRACTED ARTICLE. SEE | Dextrans [adverse effects; therapeutic use] | HYDROXYETHYL STARCH SOLUTION | MAJOR ORTHOPEDIC-SURGERY | Plasma Substitutes [adverse effects; therapeutic use] | Rehydration Solutions [adverse effects; therapeutic use] | Plasma Substitutes - therapeutic use | Resuscitation - methods | Fluid Therapy - mortality | Colloids - therapeutic use | Blood Proteins - therapeutic use | Serum Albumin, Human | Serum Albumin - therapeutic use | Fluid Therapy - methods | Serum Globulins - therapeutic use | Hydroxyethyl Starch Derivatives - therapeutic use | Dextrans - therapeutic use | Rehydration Solutions - therapeutic use | Resuscitation - mortality
Journal Article
Vox Sanguinis, ISSN 0042-9007, 05/2015, Volume 108, Issue 4, pp. 417 - 424
Background and Objectives Cryopreservation of peripheral blood hematopoietic progenitor/stem cells (PBPCs) requires the addition of cryoprotectant such as...
dimethyl sulphoxide | autologous transplantation | hematopoietic recovery | cryopreservation | peripheral blood hematopoietic stem and progenitor cells | Peripheral blood hematopoietic stem and progenitor cells | Autologous transplantation | Cryopreservation | Hematopoietic recovery | Dimethyl sulphoxide | HEMATOLOGIC RECONSTITUTION | STEM-CELLS | VIABILITY | LONG-TERM CRYOPRESERVATION | BONE-MARROW TRANSPLANTATION | CFU-GM | UMBILICAL-CORD BLOOD | POSTTHAW RECOVERY | 10-PERCENT DIMETHYL-SULFOXIDE | HEMATOLOGY | 5-PERCENT | Hematopoietic Stem Cells - drug effects | Cell Survival | Humans | Middle Aged | Blood Preservation - methods | Dimethyl Sulfoxide - pharmacology | Transplantation, Autologous - methods | Hematopoiesis - drug effects | Cryoprotective Agents - pharmacology | Albumins - pharmacology | Hematopoietic Stem Cells - cytology | Adult | Female | Aged | Hematopoietic Stem Cell Transplantation - methods | Albumin | Autografts | Transplantation | Comparative analysis | Hematopoietic stem cells | Hematology | Stem cells
dimethyl sulphoxide | autologous transplantation | hematopoietic recovery | cryopreservation | peripheral blood hematopoietic stem and progenitor cells | Peripheral blood hematopoietic stem and progenitor cells | Autologous transplantation | Cryopreservation | Hematopoietic recovery | Dimethyl sulphoxide | HEMATOLOGIC RECONSTITUTION | STEM-CELLS | VIABILITY | LONG-TERM CRYOPRESERVATION | BONE-MARROW TRANSPLANTATION | CFU-GM | UMBILICAL-CORD BLOOD | POSTTHAW RECOVERY | 10-PERCENT DIMETHYL-SULFOXIDE | HEMATOLOGY | 5-PERCENT | Hematopoietic Stem Cells - drug effects | Cell Survival | Humans | Middle Aged | Blood Preservation - methods | Dimethyl Sulfoxide - pharmacology | Transplantation, Autologous - methods | Hematopoiesis - drug effects | Cryoprotective Agents - pharmacology | Albumins - pharmacology | Hematopoietic Stem Cells - cytology | Adult | Female | Aged | Hematopoietic Stem Cell Transplantation - methods | Albumin | Autografts | Transplantation | Comparative analysis | Hematopoietic stem cells | Hematology | Stem cells
Journal Article